Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DUK | SO |
|---|---|---|
| Price | $113.89 | $83.29 |
| Change today | ▼ 0.25% | ▼ 0.22% |
| Market cap | $88.80B | $95.81B |
| Return, 3 months | -9.2% | -12.3% |
| Return, year to date | -0.3% | -2.1% |
| Return, 1 year | -4.7% | -8.9% |
| P/E (TTM) | 17.1 | 20.1 |
| P/B | 1.7 | 2.4 |
| P/E percentile vs own 5y | 0th | 22nd |
| Dividend yield | 3.74% | 3.58% |
| Revenue growth (YoY, latest qtr) | +1.1% | +0.1% |
| Net profit growth (YoY) | +13.7% | +39.3% |
| Gross margin | 51.3% | 48.3% |
| Operating margin | 26.6% | 24.2% |
| Net margin | 15.6% | 15.4% |
| Return on equity | 10.0% | 12.7% |
| Analyst target vs. price | +20.3% | +17.9% |
| Analyst buy share | 57% | 25% |
| RSI (14) | 28 | 25 |
| 30-day volatility | 12.5% | 12.9% |
| Max drawdown, 1 year | -12.3% | -15.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.